Skip to main content

Table 3 Intraocular pressure safety parameters

From: Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study

Parameter, n (%)

Monotherapy n = 84

Combination therapy n = 205

P Value

At any time during study

   

 Increase from baseline ≥10 mm Hg

20 (23.8)

71 (34.6)

0.072

 Post-baseline IOP ≥25 mm Hg

21 (25.0)

76 (37.1)

0.048

 Post-baseline IOP ≥35 mm Hg

5 (6.0)

22 (10.7)

0.205

At final visit

   

 Increase from baseline ≥10 mm Hg

3 (3.6)

9 (4.4)

>0.999

 IOP ≥25 mm Hg

3 (3.6)

11 (5.4)

0.764

 IOP ≥35 mm Hg

1 (1.2)

4 (2.0)

>0.999

Glaucoma surgery (laser/incisional)

1 (1.2)

8 (3.9)

0.455

 Laser

1 (1.2)

3 (1.5)

>0.999

 Incisional

0 (0.0)

5 (2.4)

0.326

IOP-lowering medication used secondary to retina treatment

20 (23.8)

64 (31.2)

0.208

  1. Abbreviation: IOP intraocular pressure.